Menu

How many boxes of Secukinumab are needed for one course of treatment?

Author: medicalhalo
Release time: 2026-02-01 22:25:32

Secukinumab (Secukinumab) Active substance in secukinumab is a monoclonal antibody designed to attach to a protein called interleukin 17A. Interleukin 17A is involved in inflammation and other immune system processes that lead to psoriasis, psoriatic arthritis, and spinal arthritis and is currently only available by prescription. Secukinumab is administered as a subcutaneous injection once weekly for

5 weeks and then monthly as maintenance therapy, with treatment conditions generally improving within 16 weeks of treatment. If there is no improvement after 16 weeks, your doctor may decide to stop treatment.xa0

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。